taking aim at the tyk2 pathway in psoriasis
Published 2 years ago • 552 plays • Length 58:51Download video MP4
Download video MP3
Similar videos
-
37:46
the tyk2 pathway as a novel nonbiologic oral therapeutic option in moderate to severe psoriasis
-
49:11
realizing the potential of tyk2 inhibition to address the burden of psoriasis
-
1:04:45
finding the right pathway in psoriasis: tyk2 as a therapeutic target in real-world practice
-
1:02:10
fine-tuning the jak/stat pathway in psoriasis
-
39:12
taking a team-based approach to moderate to severe psoriasis in an era of expanding oral treatment
-
1:01:26
drs. armstrong & gordon discuss the latest psoriasis updates from #aad2021 https://bit.ly/3mr1fto
-
29:59
potential clinical implications of the latest data on approved and emerging therapies for psoriasis
-
10:49
new psoriasis treatments: jak inhibitors, tyk2 inhibitors... | what's new for psoriasis treatments
-
22:09
tyk2 inhibitors for the treatment of psoriasis | ronald vender, md, frcpc | canada
-
2:30
tyk2 inhibitor_azothbio
-
2:32
how do you explain the difference between the jak and tyk2 moas?
-
4:33
il-17 family cytokines involved in psoriasis, m.a.x. tollenaere et al
-
1:05:17
immunology in the perspective of comorbidities and early intervention
-
34:23
recent advances in the treatment of moderate-to-severe psoriasis: a focus on targeted agents
-
1:45
dr. jack cush - best thing i saw today in psoriatic disease
-
3:03
what is tasquinimod?
-
5:31
psoriasis, everything you need to know | the tmi show
-
2:26
itp: second-line therapy
-
5:11
use of il-23 inhibitors to treat plaque psoriasis